More drug/IVD collaborations related to cancer therapies, as well as two agreements between device companies and universities, lead the list of noteworthy Pacts In Medtech for September and October collected by Informa's Strategic Transactions.
For the second time in a row, pharma-giant Pfizer Inc. makes the list with a collaboration with an in vitro diagnostics company. In August,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?